NGF-independent survival of postganglionic sympathetic neurons in neuronal-vascular smooth muscle cocultures

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 280, Issue 4 49-4, 2001, Pages

  Damon, Deborah H ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

Endothelin; Neuronal development; Neurotrophins

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR; NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; NERVE CELL DIFFERENTIATION; NONHUMAN; POSTGANGLIONIC NERVE; PRIORITY JOURNAL; RAT; SUPERIOR CERVICAL GANGLION; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE CELL; VASCULAR SMOOTH MUSCLE;

EID: 0035008906     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.2001.280.4.h1722     Document Type: Article

References (26)

1. Belliveau DJ, Krivko I, Kohn J, Lachance C, Pozniak C, Rusakov D, Kaplan D, and Miller FD. NGF and neurotrophin-3 both activate TrkA on sympathetic neurons but differentially regulate survival and neuritogenesis. J Cell Biol 136: 375-388, 1997.
2. Bonin LR and Damon DH. Vascular cell interactions modulate the expression of endothelin-1 and platelet-derived growth factor BB. Am J Physiol Heart Circ Physiol 267: H1698-H1706, 1994.
3. Clark DWJ. Effects of immumosympathectomy on development of high blood pressure in genetically hypertensive rats. Circ Res 28: 330-336, 1971.
4. Damon DH. Postganglionic sympathetic neurons express endothelin. Am J Physiol Regulatory Integrative Comp Physiol 274: R873-R878, 1998.
5. 2 and endothelin. Am J Physiol Heart Circ Physiol 278: H404-H411, 2000.
6. Damon DH. Endothelin and postganglionic sympathetic neurons. Clin Exp Pharmacol Physiol 26: 1000-1003, 1999.
7. Donovan MJ, Miranda RC, Kraemer R, McCaffrey TA, Tessarollo L, Mahadeo D, Shrif S, Kaplan DR, Tsoulfas P, Parada L, Toran-Allerand CD, Hajjar DP, and Hempstead BL. Neurotrophin and neurotrophin receptors in vascular smooth muscle cells: regulation of expression in response to injury. Am J Pathol 147: 309-324, 1995.
8. Ehrenreich H, Nau TR, Dembowski C, Hasselblatt M, Barth M, Hahn A, Schilling L, Siren AL, and Bruck W. Endothelin B receptor deficiency is associated with an increased rate of neuronal apoptosis in the dentate gyrus. Neuroscience 95: 993-1001, 2000.
9. Johnson EM Jr, O'Brien F, and Werbitt R. Modification and characterization of the permanent sympathectomy produced by the administration of guanethidine to newborn rats. Eur J Pharmacol 37: 45-54, 1976.
10. Lahav R, Dupin E, Lecoin L, Glavieux C, Champeval D, Ziller C, and Le Douarin NM. Endothelin 3 selectively promotes survival and proliferation of neural crest-derived glial and melanocytic precursors in vitro. Proc Natl Acad Sci USA 95: 14214-14219, 1998.
11. Levi-Montalcini R and Angeletti PU. Nerve growth factor. Physiol Rev 48: 534-569, 1968.
12. Levi-Montalcini R and Booker B. Destruction of the sympathetic ganglia in mammals by an antiserum to nerve-growth protein. Proc Natl Acad Sci USA 46: 384-391, 1960.
13. Ma Y, Campenot RB, and Miller FD. Concentration-dependent regulation of neuronal gene expression by nerve growth factor. J Cell Biol 117: 135-141, 1992.
14. Mutafova-Yambolieva VN and Westfall DP. Endothelin-3 can both facilitate and inhibit transmitter release in the guinea-pig vas deferens. Eur J Pharmacol 285: 213-216, 1995.
15. Mutafova-Yambolieva VN and Westfall DP. Inhibitory and facilitatory presynaptic effects of endothelin on sympathetic cotransmission in the rat isolated tail artery. Br J Pharmacol 123: 136-142, 1998.
16. Nambi P, Elshourbagy N, Wu HL, Pullen M, Ohlstein EH, Brooks DP, Lago MA, Elliott JD, Gleason JG, and Ruffolo RR Jr. Nonpeptide endothelin receptor antagonists II. Pharmacological characterization of SB 209670. J Pharmacol Exp Ther 271: 755-761, 1994.
17. Ross R. The smooth muscle cell. II. Growth of smooth muscle in culture and formation of elastic fibers. J Cell Biol 50: 172-186, 1971.
18. Shichiri M, Sedivy JM, Marumo F, and Hirata Y. Endothelin-1 is a potent survival factor for c-myc-dependent apoptosis. Mol Endocrinol 12: 172-180, 1998.
19. Shichiri M, Yokokura M, Marumo F, and Hirata Y. Endothelin-1 inhibits apoptosis of vascular smooth muscle cells induced by nitric oxide and serum deprivation via MAP kinase pathway. Arterioscler Thromb Vasc Biol 20: 989-997, 2000.
20. Snider WD. Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77: 627-638, 1994.
21. Sondell M, Lundborg G, and Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J Neurosci 19: 5731-5740, 1999.
22. Voyta JC, Via DP, Butterfield CE, and Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated low density lipoprotein. J Cell Biol 99: 2034-2030, 1984.
23. Wiklund NP, Ohlen A, and Cederqvist B. Inhibition of adrenergic neuroeffector transmission by endothelin in the guinea-pig femoral artery. Acta Physiol Scand 134: 311-312, 1988.
24. Zaimis E and Berk L. Morphological, biochemical and functional changes in the sympathetic nervous system of rats treated with nerve growth factor-antiserum. Nature 206: 1220-1222, 1965.
25. Zettler C, Head RJ, and Rush RA. Chronic nerve growth factor treatment of normotensive rats. Brain Res 538: 251-262, 1991.
26. Zhou XF and Rush RA. Sympathetic neurons in neonatal rats require endogenous neurotrophin-3 for survival. J Neurosci 15: 6521-6530, 1995.